BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rudberg AS, Havervall S, Månberg A, Jernbom Falk A, Aguilera K, Ng H, Gabrielsson L, Salomonsson AC, Hanke L, Murrell B, McInerney G, Olofsson J, Andersson E, Hellström C, Bayati S, Bergström S, Pin E, Sjöberg R, Tegel H, Hedhammar M, Phillipson M, Nilsson P, Hober S, Thålin C. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun 2020;11:5064. [PMID: 33033249 DOI: 10.1038/s41467-020-18848-0] [Cited by in Crossref: 179] [Cited by in F6Publishing: 192] [Article Influence: 89.5] [Reference Citation Analysis]
Number Citing Articles
1 Kittang BR, Blomberg B, Sævik M, Olofsson JS, Langeland N, Cox RJ, Bergen COVID-19 Research Group. SARS CoV-2 Infection among Health Care Workers from Different Health Care Facilities in Western Norway: A Prospective, Cross-Sectional Study. Viruses 2022;14:2652. [DOI: 10.3390/v14122652] [Reference Citation Analysis]
2 Thunell E, Peter M, Lenoir V, Andersson P, Landis B, Becker M, Lundström J. Effects of COVID-19 on the Human Central Olfactory System: A Natural Pre-Post Experiment. AJNR Am J Neuroradiol 2022. [DOI: 10.3174/ajnr.a7713] [Reference Citation Analysis]
3 Li M, Hua Y, Liao Y, Zhou L, Li X, Wang L, Yang J. Tracking the Impact of COVID-19 and Lockdown Policies on Public Mental Health Using Social Media: Infoveillance Study. J Med Internet Res 2022;24:e39676. [PMID: 36191167 DOI: 10.2196/39676] [Reference Citation Analysis]
4 Sengupta A, Azharuddin M, Johanna E, Daniel A, Selegård R, Naeimipour S, von Castelmur E, Wahlin A, Sunnerhagen M, Pietras Z, Patra HK, Al-otaibi N, Sigvardsson M, Håkan H, Katarina N, Östholm-balkhed Å, Hinkula J. Long-term systemic and mucosal humoral response in SARS- CoV-2 vaccinated post-Covid-19 infected patients.. [DOI: 10.21203/rs.3.rs-2113175/v1] [Reference Citation Analysis]
5 Blom K, Havervall S, Marking U, Norin NG, Bacchus P, Groenheit R, Bråve A, Thålin C, Klingström J. Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022. Emerg Infect Dis 2022;28:2119-21. [PMID: 35997692 DOI: 10.3201/eid2810.221093] [Reference Citation Analysis]
6 Zeeb M, Weissberg D, Rampini SK, Müller R, Scheier T, Zingg W, Kouyos RD, Wolfensberger A. Identifying Contact Risks for SARS-CoV-2 Transmission to Healthcare Workers during Outbreak on COVID-19 Ward. Emerg Infect Dis 2022;28:2134-7. [PMID: 36001791 DOI: 10.3201/eid2810.220266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sahakyan S, Musheghyan L, Aslanyan L, Grigoryan Z, Muradyan D, Khachadourian V. COVID-19 Pandemic and Frontline Health Care Workers in Armenia: A Multi-Center Study.. [DOI: 10.21203/rs.3.rs-1925400/v1] [Reference Citation Analysis]
8 Jacot D, von Rotz U, Blondet F, Aebischer O, Matthieu P, De Rham M, Pantaleo G, Marchetti O, Greub G. SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave. J Med Microbiol 2022;71. [PMID: 35921229 DOI: 10.1099/jmm.0.001558] [Reference Citation Analysis]
9 Römmele C, Kahn M, Zellmer S, Muzalyova A, Hammel G, Bartenschlager C, Beyer A, Rosendahl J, Schlittenbauer T, Zenk J, Al-nawas B, Frankenberger R, Hoffmann J, Arens C, Lammert F, Traidl-hoffmann C, Messmann H, Ebigbo A. Factors associated with an increased risk of SARS-CoV-2 infection in healthcare workers in aerosol-generating disciplines. Z Gastroenterol 2022. [DOI: 10.1055/a-1845-2979] [Reference Citation Analysis]
10 Al-Tawfiq JA, Temsah MH. Perspective on the challenges of COVID-19 facing healthcare workers. Infection 2022. [PMID: 35781868 DOI: 10.1007/s15010-022-01882-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Blom K, Marking U, Havervall S, Norin NG, Gordon M, García M, Tecleab T, Christ W, Forsell M, Phillipson M, Nilsson P, Mangsbo S, Hober S, Åberg M, Klingström J, Thålin C. Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection. The Lancet Infectious Diseases 2022;22:943-5. [DOI: 10.1016/s1473-3099(22)00362-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
12 Fredriksson L, Cederlund A, Murray M, Jansson L, Skott P. Prevalence of ongoing or previous SARS-CoV-2 infection among dental personnel - the Swedish experience. Acta Odontol Scand 2022;:1-5. [PMID: 35771959 DOI: 10.1080/00016357.2022.2095023] [Reference Citation Analysis]
13 El Moussaoui M, Maes N, Hong SL, Lambert N, Gofflot S, Dellot P, Belhadj Y, Huynen P, Hayette MP, Meex C, Bontems S, Defêche J, Godderis L, Molenberghs G, Meuris C, Artesi M, Durkin K, Rahmouni S, Grégoire C, Beguin Y, Moutschen M, Dellicour S, Darcis G. Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium. Viruses 2022;14:1302. [PMID: 35746774 DOI: 10.3390/v14061302] [Reference Citation Analysis]
14 Delgado-Losada ML, Bouhaben J, Ruiz-Huerta C, Canto MV, Delgado-Lima AH. Long-Lasting Olfactory Dysfunction in Hospital Workers Due to COVID-19: Prevalence, Clinical Characteristics, and Most Affected Odorants. Int J Environ Res Public Health 2022;19:5777. [PMID: 35565169 DOI: 10.3390/ijerph19095777] [Reference Citation Analysis]
15 Decarreaux D, Pouquet M, Souty C, Vilcu A, Prévot-monsacre P, Fourié T, Villarroel PMS, Priet S, Blanché H, Sebaoun J, Deleuze J, Turbelin C, Werner A, Kochert F, Grosgogeat B, Rabiega P, Laupie J, Abraham N, Guerrisi C, Noël H, Van der Werf S, Carrat F, Hanslik T, Charrel R, De Lamballerie X, Blanchon T, Falchi A. Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France. Viruses 2022;14:957. [DOI: 10.3390/v14050957] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Markovic-denic L, Zdravkovic M, Ercegovaca M, Djukic V, Nikolic V, Cujic D, Micic D, Pekmezovic T, Marusic V, Popadic V, Crnokrak B, Toskovic B, Klasnj S, Manojlovic A, Brankovic M, Mioljevic V, Perisic, E Z, Djordjevic M, Vukasinovic S, Mihajlovic S, Ostojic O. Seroprevalence in health care workers during the later phase of the second wave: results of three hospitals in Serbia, prior to vaccine administration. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.05.009] [Reference Citation Analysis]
17 Havervall S, Marking U, Greilert-Norin N, Gordon M, Ng H, Christ W, Phillipson M, Nilsson P, Hober S, Blom K, Klingström J, Mangsbo S, Åberg M, Thålin C. Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time. Clin Transl Immunology 2022;11:e1388. [PMID: 35444806 DOI: 10.1002/cti2.1388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
18 Myers NT, Laumbach RJ, Black KG, Ohman‐strickland P, Alimokhtari S, Legard A, De Resende A, Calderón L, Lu FT, Mainelis G, Kipen HM. Portable air cleaners and residential exposure to SARS‐CoV‐2 aerosols: A real‐world study. Indoor Air 2022;32. [DOI: 10.1111/ina.13029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Marking U, Havervall S, Greilert Norin N, Bladh O, Christ W, Gordon M, Ng H, Blom K, Phillipson M, Mangsbo S, Smed Sörensen A, Nilsson P, Hober S, Åberg M, Klingström J, Thålin C. Correlates of protection, viral load trajectories and symptoms in BA.1, BA.1.1 and BA.2 breakthrough infections in triple vaccinated healthcare workers.. [DOI: 10.1101/2022.04.02.22273333] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
20 Ladoire S, Rederstorff E, Goussot V, Parnalland S, Briot N, Ballot E, Truntzer C, Ayati S, Bengrine-lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet J, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-lamm A, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study. European Journal of Cancer 2022;165:13-24. [DOI: 10.1016/j.ejca.2022.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Laurén I, Havervall S, Ng H, Lord M, Pettke A, Greilert-Norin N, Gabrielsson L, Chourlia A, Amoêdo-Leite C, Josyula VS, Eltahir M, Kerzeli I, Falk AJ, Hober J, Christ W, Wiberg A, Hedhammar M, Tegel H, Burman J, Xu F, Pin E, Månberg A, Klingström J, Christoffersson G, Hober S, Nilsson P, Philipson M, Dönnes P, Lindsay R, Thålin C, Mangsbo S. Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology. Immun Inflamm Dis 2022;10:e595. [PMID: 35349756 DOI: 10.1002/iid3.595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Dávila-Conn V, Soto-Nava M, Caro-Vega YN, Paz-Juárez HE, García-Esparza P, Tapia-Trejo D, Pérez-García M, Belaunzarán-Zamudio PF, Reyes-Terán G, Sierra-Madero JG, Galindo-Fraga A, Ávila-Ríos S. Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico City. PLoS One 2022;17:e0264964. [PMID: 35298500 DOI: 10.1371/journal.pone.0264964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Arkell P, Gusmao C, Sheridan SL, Tanesi MY, Gomes N, Oakley T, Wapling J, Alves L, Kopf S, Sarmento N, Barreto IDC, Amaral S, Draper AD, Coelho D, Guterres H, Salles A, Machado F, Fancourt NS, Yan J, Marr I, Macartney K, Francis JR. Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste. Int J Infect Dis 2022:S1201-9712(22)00183-7. [PMID: 35358723 DOI: 10.1016/j.ijid.2022.03.043] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Darvishian M, Sharafkhah M, Mohammadi Z, Sadeghniiat-haghighi K, Abdollahi A, Jafary M, Talaschian M, Tabarsi P, Baghai P, Mardani M, Shayanrad A, Shafighian F, Markarian M, Roozafzai F, Zamani M, Alvand S, Hariri S, Sadeghi A, Poustchi H, Malekzadeh R. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran. Front Public Health 2022;10:832003. [DOI: 10.3389/fpubh.2022.832003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Pande R, Mohod SS, V P, Shanbhag S, Kumar NS. Impact of the COVID-19-induced lockdown on the incidence of ocular trauma presenting to a tertiary care hospital. BMJ Open Ophth 2022;7:e000861. [DOI: 10.1136/bmjophth-2021-000861] [Reference Citation Analysis]
26 Utzet M, Benavides FG, Villar R, Burón A, Sala M, López LE, Gomar P, Castells X, Diaz P, Ramada JM, Serra C. Non-Pharmacological Preventive Measures Had an Impact on COVID-19 in Healthcare Workers before the Vaccination Effect: A Cohort Study. Int J Environ Res Public Health 2022;19:3628. [PMID: 35329313 DOI: 10.3390/ijerph19063628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kanakan A, Mehta P, Devi P, Saifi S, Swaminathan A, Maurya R, Chattopadhyay P, Tarai B, Das P, Jha V, Budhiraja S, Pandey R. Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations? Front Microbiol 2022;13:763169. [DOI: 10.3389/fmicb.2022.763169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Correia RF, da Costa ACC, Moore DCBC, Gomes Junior SC, de Oliveira MPC, Zuma MCC, Galvani RG, Savino W, Bonomo AC, Vasconcelos ZFM, Artmann E. SARS-CoV-2 seroprevalence and social inequalities in different subgroups of healthcare workers in Rio de Janeiro, Brazil. Lancet Reg Health Am 2022;7:100170. [PMID: 35005692 DOI: 10.1016/j.lana.2021.100170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Kolodziej L, Hordijk S, Koopsen J, Maas J, Thung H, Spijkerman I, Jonges M, Bomers M, Sikkens J, Jong D, Zonneveld R, Schinkel J. SARS-CoV-2 transmission risk upon return to work in RNA-positive healthcare workers. Journal of Hospital Infection 2022. [DOI: 10.1016/j.jhin.2022.02.024] [Reference Citation Analysis]
30 Tsuchiya H. Gustatory and Saliva Secretory Dysfunctions in COVID-19 Patients with Zinc Deficiency. Life 2022;12:353. [DOI: 10.3390/life12030353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Marking U, Havervall S, Greilert-norin N, Ng H, Blom K, Nilsson P, Phillipson M, Hober S, Nilsson C, Mangsbo S, Christ W, Klingström J, Gordon M, Åberg M, Thålin C. Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines. Vaccines 2022;10:359. [DOI: 10.3390/vaccines10030359] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
32 Iravani B, Arshamian A, Lundström JN. Olfactory loss is an early and reliable marker for COVID-19.. [DOI: 10.1101/2022.02.23.22271409] [Reference Citation Analysis]
33 Keller C, Chung H, Jerrentrup A, Feldmann L, Rohde C, Halwe S, Wölfel F, Günther S, Renz H. Prevalence of SARS-CoV-2 antibodies in hospital employees, Central Germany. LaboratoriumsMedizin 2022;46:61-69. [DOI: 10.1515/labmed-2021-0107] [Reference Citation Analysis]
34 Kumar D, Burma A, Mandal AK, Joshy V. A Comparative Analysis of COVID-19 IgG Antibody Level and Socio-Demographic Status in Symptomatic and Symptomatic Population of South Andaman, India. Cureus 2022. [DOI: 10.7759/cureus.22398] [Reference Citation Analysis]
35 Korona-Głowniak I, Mielnik M, Podgajna M, Grywalska E, Hus M, Matuska K, Wojtysiak-Duma B, Duma D, Glowniak A, Malm A. SARS-CoV-2 Seroprevalence in Healthcare Workers before the Vaccination in Poland: Evolution from the First to the Second Pandemic Outbreak. Int J Environ Res Public Health 2022;19:2319. [PMID: 35206504 DOI: 10.3390/ijerph19042319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
36 Knežević D, Petković M, Božić L, Miljuš N, Mijović B, Aćimović J, Djaković-Dević J, Puhalo-Sladoje D, Mašić S, Spaić D, Todorović N, Pilipović-Broćeta N, Petrović V, Bokonjić D, Stojiljković MP, Škrbić R. Seroprevalence of SARS-CoV-2 antibodies among primary healthcare workers in the Republic of Srpska, Bosnia & Herzegovina: A cross-sectional study. Acta Microbiol Immunol Hung 2022. [PMID: 35156939 DOI: 10.1556/030.2022.01706] [Reference Citation Analysis]
37 Guarino C, Larson E, Babasyan S, Rollins A, Joshi LR, Laverack M, Parrilla L, Plocharczyk E, Diel DG, Wagner B. Development of a quantitative COVID-19 multiplex assay and its use for serological surveillance in a low SARS-CoV-2 incidence community. PLoS One 2022;17:e0262868. [PMID: 35061843 DOI: 10.1371/journal.pone.0262868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Bosdriesz JR, Ritsema F, Leenstra T, Petrignani MWF, Bruisten SM, Coyer L, Schreijer AJM, van Duijnhoven YTHP, Schim van der Loeff MF, Matser AA. Self-reported symptoms as predictors of SARS-CoV-2 infection in the general population living in the Amsterdam region, the Netherlands. PLoS ONE 2022;17:e0262287. [DOI: 10.1371/journal.pone.0262287] [Reference Citation Analysis]
39 Havervall S, Jernbom Falk A, Klingström J, Ng H, Greilert-Norin N, Gabrielsson L, Salomonsson AC, Isaksson E, Rudberg AS, Hellström C, Andersson E, Olofsson J, Skoglund L, Yousef J, Pin E, Christ W, Olausson M, Hedhammar M, Tegel H, Mangsbo S, Phillipson M, Månberg A, Hober S, Nilsson P, Thålin C. SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection. PLoS One 2022;17:e0262169. [PMID: 35020778 DOI: 10.1371/journal.pone.0262169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
40 Tomczyk S, Hönning A, Hermes J, Grossegesse M, Hofmann N, Michel J, Neumann M, Nitsche A, Hoppe B, Eckmanns T, Schmidt-traub H, Zappel K. Longitudinal SARS-CoV-2 seroepidemiological investigation among healthcare workers at a tertiary care hospital in Germany. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07057-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
41 Tognetti A, Thunell E, Olsson MJ, Greilert N, Havervall S, Thålin C, Lundström JN. High prevalence of olfactory disorders 18 months after contracting COVID-19.. [DOI: 10.1101/2022.01.20.22269490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
42 Guiomar R, Santos AJ, Melo AM, Costa I, Matos R, Rodrigues AP, Kislaya I, Silva AS, Roque C, Nunes C, Aguiar J, Graça F, Silva Graça A, Machado A. Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination. Vaccines 2022;10:154. [DOI: 10.3390/vaccines10020154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Putong N, Agrupis KA, Villanueva AM, Suzuki S, Sayo AR, Dimaano E, de Guzman F, Teaño R, Salazar MJ, Evangelista JW, Dimapilis A, Villarama JB, Ariyoshi K, Takahashi K, Smith C. A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines. Lancet Reg Health West Pac 2022;18:100353. [PMID: 35005666 DOI: 10.1016/j.lanwpc.2021.100353] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Shah VP, Breeher LE, Alleckson JM, Rivers DG, Wang Z, Stratton ER, Farah W, Hainy CM, Swift MD. Occupational exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and risk of infection among healthcare personnel. Infect Control Hosp Epidemiol 2022. [DOI: 10.1017/ice.2021.533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Sølund C, Underwood AP, Fernandez-Antunez C, Bollerup S, Mikkelsen LS, Villadsen SL, Fahnøe U, Winckelmann AA, Feng S, Nørløv Vinten CA, Dalegaard MI, Vizgirda G, Sørensen AL, Ramirez S, Bukh J, Weis N. Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA-mRNA or Vector-mRNA COVID-19 Vaccines. Vaccines (Basel) 2022;10:75. [PMID: 35062736 DOI: 10.3390/vaccines10010075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Burdalska D, Konka A, Woroszyło S, Piórkowska K, Zembala-john J, Golec M, Fronczek M, Bułdak RJ. SARS-CoV-2 antibody screening in healthcare workers: lessons learned from the first months of COVID-19 outbreak in Europe. Significance of serology testing for effective pandemic management and reduction of the occupational risk. Polish Journal of Public Health 2022;132:1-10. [DOI: 10.2478/pjph-2022-0001] [Reference Citation Analysis]
47 Amer HA, Abdallah HA, Alkheledan HS, Alzarzour SH, Shrahily A, Tamim H, Alqahtani SA, Memish ZA. SARS-CoV-2 Antibody Prevalence among Healthcare Workers: A Cross-Sectional Study at a Quaternary Healthcare Center in Saudi Arabia. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.01.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Chisanga M, Stuible M, Gervais C, L'abbé D, Cass B, Bisson L, Pelletier A, Lord-dufour S, Durocher Y, Boudreau D, Trottier S, Pelletier JN, Masson J. SERS-based assay for multiplexed detection of cross-reactivity and persistence of antibodies against the spike of the native, P.1 and B.1.617.2 SARS-CoV-2 in non-hospitalised adults. Sens Diagn 2022;1:851-866. [DOI: 10.1039/d2sd00073c] [Reference Citation Analysis]
49 Iravani B, Arshamian A, Lundström JN. Loss of olfactory sensitivity is an early and reliable marker for COVID-19. Chem Senses 2022;47:bjac022. [PMID: 36069508 DOI: 10.1093/chemse/bjac022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Thunell E, Peter MG, Lenoir V, Andersson P, Landis BN, Becker M, Lundström JN. Effects of Covid-19 on the human central olfactory system: a natural pre-post experiment.. [DOI: 10.1101/2021.12.27.21268455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Zuñiga M, Lagomarcino AJ, Muñoz S, Alonso AP, Rodriguez MA, O'Ryan ML. A cross sectional study found differential risks for COVID-19 seropositivity amongst health care professionals in Chile. J Clin Epidemiol 2021:S0895-4356(21)00433-9. [PMID: 34965480 DOI: 10.1016/j.jclinepi.2021.12.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
52 Almazán NM, Rahbar A, Carlsson M, Hoffman T, Kolstad L, Rönnberg B, Pantalone MR, Fuchs IL, Nauclér A, Ohlin M, Sacharczuk M, Religa P, Amér S, Molnár C, Lundkvist Å, Susrud A, Sörensen B, Söderberg-nauclér C. Influenza A H1N1–mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics.. [DOI: 10.1101/2021.12.23.21268321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Rodríguez de Limia Ramírez K, Ruiz-Robledillo N, Duro-Torrijos JL, García-Román V, Albaladejo-Blázquez N, Ferrer-Cascales R. Prevalence of SARS-CoV-2 Infection in a Sample of Health Workers in Two Health Departments of the Valencian Community in Spain. Int J Environ Res Public Health 2021;19:66. [PMID: 35010325 DOI: 10.3390/ijerph19010066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
54 Pimenoff VN, Elfström M, Conneryd Lundgren K, Klevebro S, Melen E, Dillner J. Potential SARS-CoV-2 infectiousness among asymptomatic healthcare workers. PLoS One 2021;16:e0260453. [PMID: 34919570 DOI: 10.1371/journal.pone.0260453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Brousseau N, Morin L, Ouakki M, Savard P, Quach C, Longtin Y, Cheng MP, Carignan A, Dufresne SF, Leduc JM, Lavallée C, Gauthier N, Bestman-Smith J, Arrieta MJ, Ishak M, Lévesque S, Martin P, De Serres G. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study. CMAJ 2021;193:E1868-77. [PMID: 34903591 DOI: 10.1503/cmaj.202783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Marklund E, Leach S, Nyström K, Lundgren A, Liljeqvist JÅ, Nilsson S, Yilmaz A, Andersson LM, Bemark M, Gisslén M. Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses. Front Immunol 2021;12:750448. [PMID: 34795668 DOI: 10.3389/fimmu.2021.750448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
57 Sherwal BL, Bhattar S, Sabharwal S, Jain A, Saxena S, Bargotya M, Dogra V. Evaluation of SARS-CoV-2 antibody responses in healthcare workers at a tertiary care COVID 19 dedicated hospital in Delhi. Indian J Med Microbiol 2021:S0255-0857(21)04714-9. [PMID: 34801631 DOI: 10.1016/j.ijmmb.2021.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Velay A, Gallais F, Wendling MJ, Bayer S, Reix N, Schneider A, Glady L, Collongues N, Lessinger JM, Hansmann Y, Kling-Pillitteri L, De Sèze J, Gonzalez M, Schmidt-Mutter C, Meyer N, Fafi-Kremer S. COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France. Infect Dis Now 2021:S2666-9919(21)00539-X. [PMID: 34775140 DOI: 10.1016/j.idnow.2021.11.002] [Reference Citation Analysis]
59 Goossens ME, Neven KY, Pannus P, Barbezange C, Thomas I, Gucht SV, Dierick K, Schmickler MN, Verbrugghe M, Loon NV, Ariën KK, Marchant A, Goriely S, Desombere I. The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. Arch Public Health 2021;79:195. [PMID: 34763723 DOI: 10.1186/s13690-021-00715-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Carapito R, Li R, Helms J, Carapito C, Gujja S, Rolli V, Guimaraes R, Malagon-Lopez J, Spinnhirny P, Lederle A, Mohseninia R, Hirschler A, Muller L, Bastard P, Gervais A, Zhang Q, Danion F, Ruch Y, Schenck M, Collange O, Chamaraux-Tran TN, Molitor A, Pichot A, Bernard A, Tahar O, Bibi-Triki S, Wu H, Paul N, Mayeur S, Larnicol A, Laumond G, Frappier J, Schmidt S, Hanauer A, Macquin C, Stemmelen T, Simons M, Mariette X, Hermine O, Fafi-Kremer S, Goichot B, Drenou B, Kuteifan K, Pottecher J, Mertes PM, Kailasan S, Aman MJ, Pin E, Nilsson P, Thomas A, Viari A, Sanlaville D, Schneider F, Sibilia J, Tharaux PL, Casanova JL, Hansmann Y, Lidar D, Radosavljevic M, Gulcher JR, Meziani F, Moog C, Chittenden TW, Bahram S. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort. Sci Transl Med 2021;:eabj7521. [PMID: 34698500 DOI: 10.1126/scitranslmed.abj7521] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 23.0] [Reference Citation Analysis]
61 Omenn GS, Lane L, Overall CM, Paik YK, Cristea IM, Corrales FJ, Lindskog C, Weintraub S, Roehrl MHA, Liu S, Bandeira N, Srivastava S, Chen YJ, Aebersold R, Moritz RL, Deutsch EW. Progress Identifying and Analyzing the Human Proteome: 2021 Metrics from the HUPO Human Proteome Project. J Proteome Res 2021. [PMID: 34670092 DOI: 10.1021/acs.jproteome.1c00590] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
62 Havervall S, Marking U, Greilert-norin N, Gordon M, Ng H, Christ W, Phillipson M, Nilsson P, Hober S, Blom K, Klingström J, Mangsbo S, Åberg M, Thålin C. Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time.. [DOI: 10.1101/2021.10.16.21264948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Herzberg J, Vollmer T, Fischer B, Becher H, Becker AK, Sahly H, Honarpisheh H, Guraya SY, Strate T, Knabbe C. Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees. Int J Environ Res Public Health 2021;18:10972. [PMID: 34682719 DOI: 10.3390/ijerph182010972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
64 Science M, Bolotin S, Silverman M, Nadarajah J, Maguire B, Parekh RS, McGeer A, Schwartz KL, Alexander L, Allen U, Ariyarajah A, Castellani L, Cohn RD, Downing M, Katz K, Kazmi K, Leis JA, Liu D, Pernica JM, Schneiderman JE, Sumaida M, Campigotto A. SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study. CMAJ Open 2021;9:E929-39. [PMID: 34642255 DOI: 10.9778/cmajo.20210044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
65 Hori H, Fukuchi T, Sanui M, Moriya T, Sugawara H. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey. PLoS One 2021;16:e0257513. [PMID: 34634076 DOI: 10.1371/journal.pone.0257513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
66 Dehnen D, Dehnen K, Trilling M, Fiedler M, Drexler J, Goralski M, Le-Trilling VTK, Schöler L, Jöckel KH, Heßbrügge M. Discrepancy between frequent occurrence of COVID-19-like symptoms and low seroconversion rates among healthcare workers. J Med Virol 2021. [PMID: 34633099 DOI: 10.1002/jmv.27385] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Abou-ElWafa HS, El-Gilany AH, Albadry AA. Self-reported COVID-19 among physicians: An Egyptian online study during the pandemic. F1000Res 2021;10:785. [PMID: 34621516 DOI: 10.12688/f1000research.53931.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Mangsbo SM, Havervall S, Laurén I, Lindsay R, Jernbom Falk A, Marking U, Lord M, Buggert M, Dönnes P, Christoffersson G, Nilsson P, Hober S, Phillipson M, Klingström J, Thålin C. An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses. PLoS One 2021;16:e0258041. [PMID: 34591918 DOI: 10.1371/journal.pone.0258041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
69 Zhang X, Sumathipala M, Zitnik M. Population-scale identification of differential adverse events before and during a pandemic. Nat Comput Sci 2021;1:666-677. [DOI: 10.1038/s43588-021-00138-4] [Reference Citation Analysis]
70 He S, Hecimovic A, Matijasevic V, Mai HT, Heslop L, Foster J, Alexander KE, Pal N, Alexandrou E, Davidson PM, Frost SA. Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis. J Clin Nurs 2021. [PMID: 34570947 DOI: 10.1111/jocn.16009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Asplund Högelin K, Ruffin N, Pin E, Månberg A, Hober S, Gafvelin G, Grönlund H, Nilsson P, Khademi M, Olsson T, Piehl F, Al Nimer F. Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis. iScience 2021;24:103078. [PMID: 34490414 DOI: 10.1016/j.isci.2021.103078] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 24.0] [Reference Citation Analysis]
72 Bailie CR, Leung VK, Orr E, Singleton E, Kelly C, Buising KL, Cowie BC, Kirk MD, Sullivan SG, Marshall C. Performance of hospital-based contact tracing for COVID-19 during Australia's second wave. Infect Dis Health 2021:S2468-0451(21)00044-4. [PMID: 34563476 DOI: 10.1016/j.idh.2021.09.001] [Reference Citation Analysis]
73 Römmele C, Ebigbo A, Kahn M, Zellmer S, Muzalyova A, Hammel G, Bartenschlager C, Beyer A, Rosendahl J, Schlittenbauer T, Zenk J, Al-nawas B, Frankenberger R, Hoffmann J, Arens C, Lammert F, Traidl-hoffmann C, Messmann H. Health-care workers in gastrointestinal endoscopy are at higher risk for SARS-CoV-2 infection compared to other aerosol-generating disciplines.. [DOI: 10.1101/2021.09.20.21263566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
74 Magaña-Guerrero FS, Trujillo DH, Buentello-Volante B, Aguayo-Flores JE, Melgoza-González EA, Hernández J, Jiménez-Martínez MC, Pérez-Tapia SM, Garfias Y. SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study. Ophthalmic Epidemiol 2021;:1-8. [PMID: 34530684 DOI: 10.1080/09286586.2021.1974493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 von Huth S, Lillevang ST, Røge BT, Madsen JS, Mogensen CB, Coia JE, Möller S, Justesen US, Johansen IS. SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark. Int J Infect Dis 2021;112:96-102. [PMID: 34534698 DOI: 10.1016/j.ijid.2021.09.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
76 Galanis P, Kaitelidou D, Prezerakos P, Kotsiopoulos I, Siskou O, Konstantakopoulou O, Hadjichristodoulou C, Tsiodras S. Low seropositivity for SARS-CoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece. Public Health 2021;198:223-9. [PMID: 34482100 DOI: 10.1016/j.puhe.2021.07.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
77 Alroqi F, Masuadi E, Alabdan L, Nogoud M, Aljedaie M, Abu-Jaffal AS, Barhoumi T, Almasoud A, Alharbi NK, Alsaedi A, Khan M, Arabi YM, Nasr A. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area. J Infect Public Health 2021;14:1268-73. [PMID: 34479078 DOI: 10.1016/j.jiph.2021.08.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Montero-Moraga JM, Buron A, Sala M, Santia P, Lupia M, Beltrán A, Villar R, Horcajada JP, Castells X, Gil OD, León EP, Serra C. Impact and Management of COVID-19 Among Healthcare Workers in Two Acute Care Hospitals and Two Associated Long-term Care Centres in Barcelona, Spain. J Occup Environ Med 2021;63:e586-91. [PMID: 34491967 DOI: 10.1097/JOM.0000000000002290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Elfström KM, Blomqvist J, Nilsson P, Hober S, Pin E, Månberg A, Pimenoff VN, Arroyo Mühr LS, Lundgren KC, Dillner J. Differences in risk for SARS-CoV-2 infection among healthcare workers. Prev Med Rep 2021;24:101518. [PMID: 34458081 DOI: 10.1016/j.pmedr.2021.101518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
80 Havervall S, Ng H, Jernbom Falk A, Greilert-Norin N, Månberg A, Marking U, Laurén I, Gabrielsson L, Salomonsson AC, Aguilera K, Kihlgren M, Månsson M, Rosell A, Hellström C, Andersson E, Olofsson J, Skoglund L, Yousef J, Pin E, Lord M, Åberg M, Hedhammar M, Tegel H, Dönnes P, Phillipson M, Nilsson P, Klingström J, Mangsbo S, Hober S, Thålin C. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19. J Intern Med 2021. [PMID: 34459525 DOI: 10.1111/joim.13387] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
81 Jolobe OMP. What are the criteria for asymptomatic status? QJM 2021;114:351-2. [PMID: 33486517 DOI: 10.1093/qjmed/hcab001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Yazaki S, Yoshida T, Kojima Y, Yagishita S, Nakahama H, Okinaka K, Matsushita H, Shiotsuka M, Kobayashi O, Iwata S, Narita Y, Ohba A, Takahashi M, Iwasa S, Kobayashi K, Ohe Y, Yoshida T, Hamada A, Doi T, Yamamoto N. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan. JAMA Oncol 2021;7:1141-8. [PMID: 34047762 DOI: 10.1001/jamaoncol.2021.2159] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 29.0] [Reference Citation Analysis]
83 Zangoue M, Safari H, Royce SG, Zangooie A, Rezapour H, Zangouei A, Fereidouni M. The high level of adherence to personal protective equipment in health care workers efficiently protects them from COVID-19 infection. Work 2021;69:1191-6. [PMID: 34421000 DOI: 10.3233/WOR-210634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
84 Madsen JR, Nielsen JPS, Fogh K, Hansen CB, Nielsen PB, Lange T, Hasselbalch RB, Garred P, Iversen K. Anti-SARS-CoV-2 Seropositivity Among Medical Students in Copenhagen. Open Forum Infect Dis 2021;8:ofab273. [PMID: 34423066 DOI: 10.1093/ofid/ofab273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
85 Neumann M, Aigner A, Rossow E, Schwarz D, Marschallek M, Steinmann J, Stücker R, Koenigs I, Stock P. Low SARS-CoV-2 seroprevalence but high perception of risk among healthcare workers at children's hospital before second pandemic wave in Germany. World J Pediatr 2021;17:484-94. [PMID: 34415560 DOI: 10.1007/s12519-021-00447-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Pınarlık F, Genç Z, Kapmaz M, Tekin S, Ergönül Ö. Risk Groups for SARS-CoV-2 Infection among Healthcare Workers: Community Versus Hospital Transmission. Infect Dis Rep 2021;13:724-9. [PMID: 34449648 DOI: 10.3390/idr13030067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
87 Havervall S, Marking U, Greilert-Norin N, Ng H, Gordon M, Salomonsson AC, Hellström C, Pin E, Blom K, Mangsbo S, Phillipson M, Klingström J, Hober S, Nilsson P, Åberg M, Thålin C. Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2. EBioMedicine 2021;70:103523. [PMID: 34391088 DOI: 10.1016/j.ebiom.2021.103523] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 26.0] [Reference Citation Analysis]
88 Cruz-Arenas E, Cabrera-Ruiz E, Laguna-Barcenas S, Colin-Castro CA, Chavez T, Franco-Cendejas R, Ibarra C, Perez-Orive J. Serological prevalence of SARS-CoV-2 infection and associated factors in healthcare workers in a "non-COVID" hospital in Mexico City. PLoS One 2021;16:e0255916. [PMID: 34383842 DOI: 10.1371/journal.pone.0255916] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
89 Havervall S, Marking U, Gordon M, Ng H, Greilert-norin N, Lindbo S, Blom K, Nilsson P, Phillipson M, Klingström J, Mangsbo S, Åberg M, Hober S, Thålin C. Neutralization of VOCs including Delta one year post COVID-19 or vaccine.. [DOI: 10.1101/2021.08.12.21261951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
90 Wratil PR, Schmacke NA, Osterman A, Weinberger T, Rech J, Karakoc B, Zeilberger M, Steffen J, Mueller TT, Spaeth PM, Stern M, Albanese M, Thun H, Reinbold J, Sandmeyer B, Kressirer P, Grabein B, Falkai P, Adorjan K, Hornung V, Kaderali L, Klein M, Keppler OT. In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers. Infection 2021. [PMID: 34379308 DOI: 10.1007/s15010-021-01672-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
91 Alkharaan H, Bayati S, Hellström C, Aleman S, Olsson A, Lindahl K, Bogdanovic G, Healy K, Tsilingaridis G, De Palma P, Hober S, Månberg A, Nilsson P, Pin E, Sällberg Chen M. Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys. J Infect Dis 2021;224:407-14. [PMID: 33978762 DOI: 10.1093/infdis/jiab256] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 21.0] [Reference Citation Analysis]
92 Ocias LF, Skogstam A, Kjerstadius T, Lundin F, Tevell S. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study. Infect Dis (Lond) 2021;:1-10. [PMID: 34350813 DOI: 10.1080/23744235.2021.1959949] [Reference Citation Analysis]
93 Vitrat V, Maillard A, Raybaud A, Wackenheim C, Chanzy B, Nguyen S, Valran A, Bosch A, Noret M, Delory T. Effect of Professional and Extra-Professional Exposure on Seroprevalence of SARS-CoV-2 Infection among Healthcare Workers of the French Alps: A Multicentric Cross-Sectional Study. Vaccines (Basel) 2021;9:824. [PMID: 34451949 DOI: 10.3390/vaccines9080824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
94 Kang M, Perl TM. The front-line during the coronavirus disease 2019 pandemic: healthcare personnel. Curr Opin Infect Dis 2021;34:372-83. [PMID: 34227581 DOI: 10.1097/QCO.0000000000000734] [Reference Citation Analysis]
95 Sarkar S, Das S, Choudhury K, Mukherjee S, Chatterjee R. Seroprevalence and Dynamics of anti-SARS-CoV-2 antibody among healthcare workers following ChAdOx1 nCoV-19 vaccination.. [DOI: 10.1101/2021.07.20.21260278] [Reference Citation Analysis]
96 Trübner F, Steigert L, Echterdiek F, Jung N, Schmidt-Hellerau K, Zoller WG, Frick JS, Feng YS, Paul G. Predictors of COVID-19 in an outpatient fever clinic. PLoS One 2021;16:e0254990. [PMID: 34288955 DOI: 10.1371/journal.pone.0254990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Dillner J, Elfström KM, Blomqvist J, Engstrand L, Uhlén M, Eklund C, Boulund F, Lagheden C, Hamsten M, Nordqvist-Kleppe S, Seifert M, Hellström C, Olofsson J, Andersson E, Falk AJ, Bergström S, Hultin E, Pin E, Pimenoff VN, Hassan S, Månberg A, Nilsson P, Hedhammar M, Hober S, Mattsson J, Arroyo Mühr LS, Lundgren KC. High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers. J Infect Dis 2021;224:14-20. [PMID: 33580261 DOI: 10.1093/infdis/jiab099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
98 da Silva Antunes R, Pallikkuth S, Williams E, Dawen Yu E, Mateus J, Quiambao L, Wang E, Rawlings SA, Stadlbauer D, Jiang K, Amanat F, Arnold D, Andrews D, Fuego I, Dan JM, Grifoni A, Weiskopf D, Krammer F, Crotty S, Hoffer ME, Pahwa SG, Sette A. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers. J Infect Dis 2021;224:70-80. [PMID: 33822097 DOI: 10.1093/infdis/jiab176] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 30.0] [Reference Citation Analysis]
99 Hober S, Hellström C, Olofsson J, Andersson E, Bergström S, Jernbom Falk A, Bayati S, Mravinacova S, Sjöberg R, Yousef J, Skoglund L, Kanje S, Berling A, Svensson AS, Jensen G, Enstedt H, Afshari D, Xu LL, Zwahlen M, von Feilitzen K, Hanke L, Murrell B, McInerney G, Karlsson Hedestam GB, Lendel C, Roth RG, Skoog I, Svenungsson E, Olsson T, Fogdell-Hahn A, Lindroth Y, Lundgren M, Maleki KT, Lagerqvist N, Klingström J, Da Silva Rodrigues R, Muschiol S, Bogdanovic G, Arroyo Mühr LS, Eklund C, Lagheden C, Dillner J, Sivertsson Å, Havervall S, Thålin C, Tegel H, Pin E, Månberg A, Hedhammar M, Nilsson P. Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay. Clin Transl Immunology 2021;10:e1312. [PMID: 34295471 DOI: 10.1002/cti2.1312] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
100 Coltart CEM, Wells D, Sutherland E, Fowler A. National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates. BMJ Open 2021;11:e049703. [PMID: 34257096 DOI: 10.1136/bmjopen-2021-049703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
101 Zhou K, Blanc-Lapierre A, Seegers V, Boisdron-Celle M, Bigot F, Bourdon M, Mahammedi H, Lambert A, Campone M, Conroy T, Penault-Llorca F, Bellanger MM, Raoul JL. Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort Study. Cancers (Basel) 2021;13:3389. [PMID: 34298605 DOI: 10.3390/cancers13143389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
102 Shamshirgaran SM, Aminisani N, Abasi H, Mollanoroozy E, Mohammad Malekzadeh M, Fazel H, Ghasemi A, khorashadizade F, Moshar-movahed G, Alimardani AS, Gholami A. Risk assessment of coronavirus disease 2019 among healthcare workers in Neyshabur, 2020. Proceedings of Singapore Healthcare. [DOI: 10.1177/20101058211028854] [Reference Citation Analysis]
103 Zhang X, Saade E, Noguez JH, Schmotzer C. SARS-CoV-2 Seroprevalence among First Responders in Northeastern Ohio.. [DOI: 10.1101/2021.06.27.21259432] [Reference Citation Analysis]
104 M R S, Govindan V, H H S, K P, V T V, Ravikumar KL. COMPARISON OF PERFORMANCE CHARACTERISTICS BETWEEN LATERAL FLOW, ELISAAND ELECTROCHEMILUMINESCENCE IMMUNOASSAYS FOR THE DETECTION OF SARS-COV-2 ANTIBODIES AMONG HEALTHCARE WORKERS. ijsr 2021. [DOI: 10.36106/ijsr/0101617] [Reference Citation Analysis]
105 Leonard A, Prior AR, Reilly P, Murray C, Brien MO, Maguire G, Ennis D, Reid A, Rakovac A, Boran G. High anti-SARS-CoV-2 antibody seroprevalence in healthcare workers in an Irish university teaching hospital. Ir J Med Sci 2021. [PMID: 34195921 DOI: 10.1007/s11845-021-02690-4] [Reference Citation Analysis]
106 Muhsen K, Schwaber MJ, Bishara J, Kassem E, Atamna A, Na'amnih W, Goren S, Bialik A, Mohsen J, Zaide Y, Hazan N, Ariel-Cohen O, Cohen R, Shitrit P, Marchaim D, Benenson S, Ben-David D, Rubinovitch B, Gotessman T, Nutman A, Wiener-Well Y, Maor Y, Carmeli Y, Cohen D. Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination. Front Med (Lausanne) 2021;8:689994. [PMID: 34249979 DOI: 10.3389/fmed.2021.689994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
107 Murongazvombo AS, Jones RS, Rayment M, Mughal N, Azadian B, Donaldson H, Davies GW, Moore LS, Aiken AM. Association between SARS-CoV-2 exposure and antibody status among healthcare workers in two London hospitals: a cross-sectional study. Infect Prev Pract 2021;3:100157. [PMID: 34316587 DOI: 10.1016/j.infpip.2021.100157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Klevebro S, Bahram F, Elfström KM, Hellberg U, Hober S, Merid SK, Kull I, Nilsson P, Tornvall P, Wang G, Conneryd Lundgren K, Ponzer S, Dillner J, Melén E. Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care. Scand J Public Health 2021;:14034948211022434. [PMID: 34148454 DOI: 10.1177/14034948211022434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
109 Åkerlund T, Zakikhany K, Löfström C, Lindmark E, Källberg H, Elofsson U, Cederbrant K, Nygren E, Kallin A, Lagerqvist N, Nilsson P, Hober S, Wollberg AR, Björndal ÅS. Stable IgG-antibody levels in patients with mild SARS-CoV-2 infection.. [DOI: 10.1101/2021.06.16.21258960] [Reference Citation Analysis]
110 van Bremen K, Monin M, Eis-Hübinger AM, Marx B, Aldabaggh S, Streeck H, Wasmuth JC, Menting T, Schlabe S, Rieke GJ, Schwarze-Zander C, Rockstroh JK, Boesecke C. SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study). Infection 2021. [PMID: 34143409 DOI: 10.1007/s15010-021-01641-6] [Reference Citation Analysis]
111 Roxhed N, Bendes A, Dale M, Mattsson C, Hanke L, Dodig-Crnković T, Christian M, Meineke B, Elsässer S, Andréll J, Havervall S, Thålin C, Eklund C, Dillner J, Beck O, Thomas CE, McInerney G, Hong MG, Murrell B, Fredolini C, Schwenk JM. Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2. Nat Commun 2021;12:3695. [PMID: 34140485 DOI: 10.1038/s41467-021-23893-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
112 Kaspersen KA, Greve T, Nielsen KJ, Jespersen S, Mikkelsen S, Vestergaard JM, Redder JD, Tolstrup M, Thomsen MK, Møller HJ, Østergaard L, Kolstad HA, Erikstrup C. Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020. Int J Infect Dis 2021;109:17-23. [PMID: 34126235 DOI: 10.1016/j.ijid.2021.06.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
113 Musa S, Abdel Alem S, Amer K, Elnagdy T, Hassan WA, Ali MA, Gaber Y, Badary HA, Tantawi O, Abdelmoniem R, Radwan A, Yousof H, Shawky S, Talaat H, Fouad R, Kassem AM. Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study. J Infect Public Health 2021:S1876-0341(21)00156-8. [PMID: 34175238 DOI: 10.1016/j.jiph.2021.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
114 Faller E, Wyse A, Barry R, Conlon K, Everard C, Finnegan P, Foran C, Herlihy E, Kerr G, Lapthorne S, McGreal-Bellone A, Morrissey E, O'Sullivan D, O'Sullivan G, Eustace JA, Spillane D, Dempsey C, Benson J, Prentice M, Gallagher J, MacSharry J, Fanning LJ, O'Riordan S, Horgan M, Sadlier C. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland. BMJ Open 2021;11:e051415. [PMID: 34103324 DOI: 10.1136/bmjopen-2021-051415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
115 Kayı İ, Madran B, Keske Ş, Karanfil Ö, Arribas JR, Psheniсhnaya N, Petrosillo N, Gönen M, Ergönül Ö. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis. Clin Microbiol Infect 2021;27:1242-9. [PMID: 34116205 DOI: 10.1016/j.cmi.2021.05.036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 21.0] [Reference Citation Analysis]
116 Stringhini S, Zaballa ME, Pullen N, de Mestral C, Perez-Saez J, Dumont R, Picazio A, Pennacchio F, Dibner Y, Yerly S, Baysson H, Vuilleumier N, Balavoine JF, Bachmann D, Trono D, Pittet D, Chappuis F, Kherad O, Kaiser L, Azman AS, Guessous I; SEROCoV-WORK + Study Group. Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nat Commun 2021;12:3455. [PMID: 34103517 DOI: 10.1038/s41467-021-23796-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
117 Abo-Leyah H, Gallant S, Cassidy D, Giam YH, Killick J, Marshall B, Hay G, Snowdon C, Hothersall EJ, Pembridge T, Strachan R, Gallant N, Parcell BJ, George J, Furrie E, Chalmers JD. The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers. ERJ Open Res 2021;7:00080-2021. [PMID: 34104643 DOI: 10.1183/23120541.00080-2021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
118 Seifi T, Reza Kamali A. Antiviral performance of graphene-based materials with emphasis on COVID-19: A review. Med Drug Discov 2021;:100099. [PMID: 34056572 DOI: 10.1016/j.medidd.2021.100099] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 26.0] [Reference Citation Analysis]
119 Freitas Neves PR, Oliveira TD, Magalhães TF, Dos Reis PRS, Tofaneli LA, Bandeira Santos AÁ, Machado BAS, Oliveira FO, da Silva Andrade LPC, Badaró R, Brêda Mascarenhas LA. Numerical and experimental analyses for the improvement of surface instant decontamination technology through biocidal agent dispersion: Potential of application during pandemic. PLoS One 2021;16:e0251817. [PMID: 34010343 DOI: 10.1371/journal.pone.0251817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
120 Kahlert CR, Persi R, Güsewell S, Egger T, Leal-Neto OB, Sumer J, Flury D, Brucher A, Lemmenmeier E, Möller JC, Rieder P, Stocker R, Vuichard-Gysin D, Wiggli B, Albrich WC, Babouee Flury B, Besold U, Fehr J, Kuster SP, McGeer A, Risch L, Schlegel M, Friedl A, Vernazza P, Kohler P. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study. Clin Microbiol Infect 2021;27:1336-44. [PMID: 34020033 DOI: 10.1016/j.cmi.2021.05.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
121 Castro Dopico X, Muschiol S, Christian M, Hanke L, Sheward DJ, Grinberg NF, Rorbach J, Bogdanovic G, Mcinerney GM, Allander T, Wallace C, Murrell B, Albert J, Karlsson Hedestam GB. Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden. J Intern Med 2021;290:666-76. [PMID: 34008203 DOI: 10.1111/joim.13304] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
122 Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, Thålin C. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. JAMA 2021;325:2015-6. [PMID: 33825846 DOI: 10.1001/jama.2021.5612] [Cited by in Crossref: 166] [Cited by in F6Publishing: 179] [Article Influence: 166.0] [Reference Citation Analysis]
123 Lewin A, Therrien R, De Serres G, Grégoire Y, Perreault J, Drouin M, Fournier MJ, Tremblay T, Beaudoin J, Beaudoin-Bussières G, Prévost J, Gendron-Lepage G, Finzi A, Bernier F, Bazin R, Germain M, Delage G. SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study. Can J Public Health 2021;112:576-86. [PMID: 33999398 DOI: 10.17269/s41997-021-00531-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
124 Supekar NT, Shajahan A, Gleinich AS, Rouhani DS, Heiss C, Chapla DG, Moremen KW, Azadi P. Variable post-translational modifications of SARS-CoV-2 nucleocapsid protein. Glycobiology 2021:cwab044. [PMID: 33997890 DOI: 10.1093/glycob/cwab044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
125 Spagnolo L, Vimercati L, Caputi A, Benevento M, De Maria L, Ferorelli D, Solarino B. Role and Tasks of the Occupational Physician during the COVID-19 Pandemic. Medicina (Kaunas) 2021;57:479. [PMID: 34065845 DOI: 10.3390/medicina57050479] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
126 Havervall S, Marking U, Greilert-norin N, Ng H, Salomonsson A, Hellström C, Pin E, Blom K, Mangsbo S, Phillipson M, Klingström J, Åberg M, Hober S, Nilsson P, Thålin C. Antibody Responses After a Single Dose of ChAdOx1 nCoV-19 Vaccine in Healthcare Workers Previously Infected with SARS-CoV-2.. [DOI: 10.1101/2021.05.08.21256866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
127 Kharlamova N, Dunn N, Bedri SK, Jerling S, Almgren M, Faustini F, Gunnarsson I, Rönnelid J, Pullerits R, Gjertsson I, Lundberg K, Månberg A, Pin E, Nilsson P, Hober S, Fink K, Fogdell-Hahn A. False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases. Front Immunol 2021;12:666114. [PMID: 34012450 DOI: 10.3389/fimmu.2021.666114] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
128 Shincy MR, Govindan V, Sudhakar HH, Venkatesha VT, Padmapriya K, Ravikumar KL. COMPARISON OF PERFORMANCE CHARACTERISTICS BETWEEN LATERAL FLOW, ELISA AND ELECTROCHEMILUMINESCENCE IMMUNOASSAYS FOR THE DETECTION OF SARS-COV-2 ANTIBODIES AMONG HEALTHCARE WORKERS.. [DOI: 10.1101/2021.04.29.21256260] [Reference Citation Analysis]
129 Mens H, Koch A, Chaine M, Bengaard Andersen A. The Hammer vs Mitigation-A comparative retrospective register study of the Swedish and Danish national responses to the COVID-19 pandemic in 2020. APMIS 2021;129:384-92. [PMID: 33754383 DOI: 10.1111/apm.13133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
130 Napolitano F, Di Giuseppe G, Montemurro MV, Molinari AM, Donnarumma G, Arnese A, Pavia M, Angelillo IF. Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy. Int J Environ Res Public Health 2021;18:4761. [PMID: 33947008 DOI: 10.3390/ijerph18094761] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
131 Bartko J, Zehetmayer S, Weseslindtner L, Stiasny K, Schloegl A, Forjan E, Zwettler E, Krauter A, Keil F, Sédille-Mostafaie N. Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe. J Clin Med 2021;10:1909. [PMID: 33924976 DOI: 10.3390/jcm10091909] [Reference Citation Analysis]
132 Al-Maani A, Al Wahaibi A, Al-Sooti J, Al Abri B, Al Shukri I, AlRisi E, Al Abri L, AlDaghari K, Al Subhi M, AlMaqbali S, AlBurtamani S, AlAbri A, Al Salami A, Al-Beloushi I, Al-Zadjali N, Alqayoudhi A, Al-Kindi H, Al Shaqsi K, Al-Jardani A, Al-Abri S. The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: A multicenter seroprevalence study. Int J Infect Dis 2021;107:257-63. [PMID: 33930541 DOI: 10.1016/j.ijid.2021.04.071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
133 Papasavas P, Olugbile S, Wu U, Robinson K, Roberts AL, O'Sullivan DM, McLaughlin T, Mather JF, Steinberg AC, Orlando R, Kumar A. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut. J Hosp Infect 2021;114:117-25. [PMID: 33930487 DOI: 10.1016/j.jhin.2021.04.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
134 Allen N, Riain UN, Conlon N, Ferenczi A, Carrion Martin AI, Domegan L, Walsh C, Doherty L, O'Farrelly C, Higgins E, Kerr C, McGrath J, Fleming C, Bergin C; PRECISE Study Steering Group. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers. Epidemiol Infect 2021;149:e157. [PMID: 33902786 DOI: 10.1017/S0950268821000984] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
135 Korth J, Wilde B, Dolff S, Frisch J, Jahn M, Krawczyk A, Trilling M, Schipper L, Cordes S, Ross B, Lindemann M, Kribben A, Dittmer U, Witzke O, Herrmann A, Anastasiou OE. SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study. Int J Environ Res Public Health 2021;18:4540. [PMID: 33922895 DOI: 10.3390/ijerph18094540] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
136 Alsuwaidi AR, Al Hosani FI, Al Memari S, Narchi H, Abdel Wareth L, Kamal H, Al Ketbi M, Al Baloushi D, Elfateh A, Khudair A, Al Mazrouei S, AlHumaidan HS, Alghaithi N, Afsh K, Al Kaabi N, Altrabulsi B, Jones M, Shaban S, Sheek-Hussein M, Zoubeidi T. Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study. Int J Epidemiol 2021:dyab077. [PMID: 33893483 DOI: 10.1093/ije/dyab077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
137 Favara DM, McAdam K, Cooke A, Bordessa-Kelly A, Budriunaite I, Bossingham S, Houghton S, Doffinger R, Ainsworth N, Corrie PG. SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic. Clin Oncol (R Coll Radiol) 2021;33:667-75. [PMID: 33941453 DOI: 10.1016/j.clon.2021.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
138 Maltezou HC, Giannouchos TV, Pavli A, Tsonou P, Dedoukou X, Tseroni M, Papadima K, Hatzigeorgiou D, Sipsas NV, Souliotis K. Costs associated with COVID-19 in healthcare personnel in Greece: a cost-of-illness analysis. J Hosp Infect 2021;114:126-33. [PMID: 33894306 DOI: 10.1016/j.jhin.2021.04.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
139 Carazo S, Laliberté D, Villeneuve J, Martin R, Deshaies P, Denis G, Adib G, Tissot F, Dionne M, De Serres G. Characterization and evolution of infection control practices among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-infected healthcare workers in acute-care hospitals and long-term care facilities in Québec, Canada, Spring 2020. Infect Control Hosp Epidemiol 2021;:1-9. [PMID: 33853702 DOI: 10.1017/ice.2021.160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
140 Vu TV, Alongi AM, Chow C, Brinster CJ, Brown RE, Fuhrman G, Money SR. The Surgeon's Risk of SARS-CoV-2 Infection During the Initial Peak of the COVID-19 Pandemic in New Orleans. Am Surg 2021;:31348211011090. [PMID: 33847533 DOI: 10.1177/00031348211011090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Hassan SS, Seigerud Å, Abdirahman R, Arroyo Mühr LS, Nordqvist Kleppe S, Pin E, Månberg A, Hober S, Nilsson P, Engstrand L, Miriam Elfström K, Blomqvist J, Conneryd Lundgren K, Dillner J. SARS-CoV-2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden. J Intern Med 2021;290:430-6. [PMID: 33843090 DOI: 10.1111/joim.13274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
142 Müller K, Girl P, Ruhnke M, Spranger M, Kaier K, von Buttlar H, Dobler G, Borde JP. SARS-CoV-2 Seroprevalence among Health Care Workers-A Voluntary Screening Study in a Regional Medical Center in Southern Germany. Int J Environ Res Public Health 2021;18:3910. [PMID: 33917840 DOI: 10.3390/ijerph18083910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
143 Elfström KM, Blomqvist J, Nilsson P, Hober S, Pin E, Månberg A, Pimenoff VN, Arroyo Mühr LS, Lundgren KC, Dillner J. Differences in risk for SARS-CoV-2 infection among healthcare workers.. [DOI: 10.1101/2021.03.30.21254653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Herzberg J, Vollmer T, Fischer B, Becher H, Becker A, Sahly H, Honarpisheh H, Guraya SY, Strate T, Knabbe C. Half Year Longitudinal Seroprevalence of SARS-CoV-2-antibodies and Rule Compliance in German Hospital Employees.. [DOI: 10.1101/2021.03.29.21254538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Žaja R, Kerner I, Macan J, Milošević M. Characteristics of work-related COVID-19 in Croatian healthcare workers: a preliminary report. Arh Hig Rada Toksikol 2021;72:36-41. [PMID: 33787182 DOI: 10.2478/aiht-2021-72-3530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
146 Airoldi C, Patrucco F, Milano F, Alessi D, Sarro A, Rossi MA, Cena T, Borrè S, Faggiano F. High Seroprevalence of SARS-CoV-2 among Healthcare Workers in a North Italy Hospital. Int J Environ Res Public Health 2021;18:3343. [PMID: 33804893 DOI: 10.3390/ijerph18073343] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
147 Woon YL, Lee YL, Chong YM, Ayub NA, Krishnabahawan SL, Lau JFW, Subramaniam-Kalianan R, Sam IC, Chan YF, Sevalingam RK, Ramli A, Chuah CH, Mat-Hussin H, Leong CL, Chidambaram SK, Peariasamy KM, Goh PP. Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia. Lancet Reg Health West Pac 2021;9:100123. [PMID: 33778796 DOI: 10.1016/j.lanwpc.2021.100123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
148 Hansen CH, Michlmayr D, Gubbels SM, Mølbak K, Ethelberg S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet 2021;397:1204-12. [PMID: 33743221 DOI: 10.1016/S0140-6736(21)00575-4] [Cited by in Crossref: 381] [Cited by in F6Publishing: 243] [Article Influence: 381.0] [Reference Citation Analysis]
149 Alkharaan H, Bayati S, Hellström C, Olsson A, Lindahl K, Bogdanovic G, Aleman S, Tsilingaridis G, De Palma P, Hober S, Månberg A, Nilsson P, Pin E, Sällberg Chen M. Persisting Salivary IgG against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.. [DOI: 10.1101/2021.03.13.21253492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
150 Tsuchiya H. Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review. Dent J (Basel) 2021;9:32. [PMID: 33799583 DOI: 10.3390/dj9030032] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 22.0] [Reference Citation Analysis]
151 Nygren D, Norén J, De Marinis Y, Holmberg A, Fraenkel C, Rasmussen M. Association between SARS-CoV-2 and exposure risks in health care workers and university employees – a cross-sectional study. Infectious Diseases 2021;53:460-8. [DOI: 10.1080/23744235.2021.1892819] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
152 Hossain A, Nasrullah SM, Tasnim Z, Hasan MK, Hasan MM. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis. EClinicalMedicine 2021;33:100770. [PMID: 33718853 DOI: 10.1016/j.eclinm.2021.100770] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 37.0] [Reference Citation Analysis]
153 Granstam E, Krifors A, Freyhult E, Åkerblom H. No findings of SARS-CoV-2 in conjunctival swabs from patients at an emergency outpatient ophthalmological healthcare facility in a Swedish county hospital: a cross-sectional study. BMJ Open Ophthalmol 2021;6:e000616. [PMID: 34041362 DOI: 10.1136/bmjophth-2020-000616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Ladoire S, Goussot V, Redersdorff E, Cueff A, Ballot E, Truntzer C, Ayati S, Bengrine-Lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet JD, Hanu R, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-Lamm AL, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F. Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study. Eur J Cancer 2021;148:359-70. [PMID: 33780664 DOI: 10.1016/j.ejca.2021.02.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
155 Handal N, Whitworth J, Blomfeldt A, Espvik HJ, Lysaker E, Berdal JE, Bakken Jørgensen S. Comparison of SARS-CoV-2 infections in healthcare workers with high and low exposures to Covid-19 patients in a Norwegian University Hospital. Infect Dis (Lond) 2021;53:420-9. [PMID: 33620274 DOI: 10.1080/23744235.2021.1885734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
156 Lombardi A, Mangioni D, Consonni D, Cariani L, Bono P, Cantù AP, Tiso B, Carugno M, Muscatello A, Lunghi G, Pesatori AC, Riboldi L, Ceriotti F, Bandera A, Gori A. Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study. BMJ Open 2021;11:e047216. [PMID: 33619203 DOI: 10.1136/bmjopen-2020-047216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
157 Díez-Manglano J, Solís-Marquínez MN, Álvarez García A, Alcalá-Rivera N, Maderuelo Riesco I, Gericó Aseguinolaza M, Beato Pérez JL, Méndez Bailón M, Labirua-Iturburu Ruiz AE, García Gómez M, Martínez Cilleros C, Pesqueira Fontan PM, Abella Vázquez L, Blázquez Encinar JC, Boixeda R, Gil Sánchez R, de la Peña Fernández A, Loureiro Amigo J, Escobar Sevilla J, Guzmán Garcia M, Martín Escalante MD, Magallanes Gamboa JO, Martínez González ÁL, Lumbreras Bermejo C, Antón Santos JM; SEMI-COVID-19 Network. Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry. PLoS One 2021;16:e0247422. [PMID: 33606820 DOI: 10.1371/journal.pone.0247422] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
158 Becker M, Strengert M, Junker D, Kaiser PD, Kerrinnes T, Traenkle B, Dinter H, Häring J, Ghozzi S, Zeck A, Weise F, Peter A, Hörber S, Fink S, Ruoff F, Dulovic A, Bakchoul T, Baillot A, Lohse S, Cornberg M, Illig T, Gottlieb J, Smola S, Karch A, Berger K, Rammensee HG, Schenke-Layland K, Nelde A, Märklin M, Heitmann JS, Walz JS, Templin M, Joos TO, Rothbauer U, Krause G, Schneiderhan-Marra N. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity. Nat Commun 2021;12:1152. [PMID: 33608538 DOI: 10.1038/s41467-021-20973-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 44.0] [Reference Citation Analysis]
159 Eyre DW, Lumley SF, O'Donnell D, Stoesser NE, Matthews PC, Howarth A, Hatch SB, Marsden BD, Cox S, James T, Cornall RJ, Stuart DI, Screaton G, Ebner D, Crook DW, Conlon CP, Jeffery K, Walker TM, Peto TEA. Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections. BMC Infect Dis 2021;21:187. [PMID: 33602152 DOI: 10.1186/s12879-021-05878-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
160 Ledda C, Carrasi F, Longombardo MT, Paravizzini G, Rapisarda V. SARS-CoV-2 Seroprevalence Post-First Wave among Primary Care Physicians in Catania (Italy). Trop Med Infect Dis 2021;6:21. [PMID: 33572221 DOI: 10.3390/tropicalmed6010021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
161 Marot S, Malet I, Leducq V, Zafilaza K, Sterlin D, Planas D, Gothland A, Jary A, Dorgham K, Bruel T, Burrel S, Boutolleau D, Schwartz O, Gorochov G, Calvez V, Marcelin AG; Sorbonne Université SARS-CoV-2 Neutralizing Antibodies Study Group. Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun 2021;12:844. [PMID: 33558507 DOI: 10.1038/s41467-021-21111-9] [Cited by in Crossref: 98] [Cited by in F6Publishing: 108] [Article Influence: 98.0] [Reference Citation Analysis]
162 Pereckaitė L, Dambrauskienė A, Urbonienė D, Sadauskas S, Petrikonis K, Naudžiūnas A, Vitkauskienė A. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic. Medicina (Kaunas) 2021;57:148. [PMID: 33562085 DOI: 10.3390/medicina57020148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
163 Klevebro S, Bahram F, Elfström KM, Hellberg U, Hober S, Merid SK, Kull I, Nilsson P, Tornvall P, Wang G, Lundgren KC, Ponzer S, Dillner J, Melén E. Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care.. [DOI: 10.1101/2021.01.28.21250664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
164 Mutiawati E, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Maliga HA, Ilmawan M, Emran TB, Ophinni Y, Ichsan I, Musadir N, Rabaan AA, Dhama K, Syahrul S, Nainu F, Harapan H. Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis. F1000Res 2021;10:40. [PMID: 33824716 DOI: 10.12688/f1000research.28393.1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 42.0] [Reference Citation Analysis]
165 da Silva Antunes R, Pallikkuth S, Williams E, Yu ED, Mateus J, Quiambao L, Wang E, Rawlings SA, Stadlbauer D, Jiang K, Amanat F, Arnold D, Andrews D, Fuego I, Dan JM, Grifoni A, Weiskopf D, Krammer F, Crotty S, Hoffer ME, Pahwa SG, Sette A. Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workers. medRxiv 2021:2021. [PMID: 33469594 DOI: 10.1101/2021.01.12.21249683] [Reference Citation Analysis]
166 Goldblatt D, Johnson M, Falup-Pecurariu O, Ivaskeviciene I, Spoulou V, Tamm E, Wagner M, Zar HJ, Bleotu L, Ivaskevicius R, Papadatou I, Jõgi P, Lischka J, Franckling-Smith Z, Isarova D, Grandjean L, Zavadska D. Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries. J Hosp Infect 2021;110:60-6. [PMID: 33422589 DOI: 10.1016/j.jhin.2020.12.019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 22.0] [Reference Citation Analysis]
167 Havervall S, Falk AJ, Klingström J, Ng H, Greilert-norin N, Gabrielsson L, Salomonsson A, Isaksson E, Rudberg A, Hellström C, Andersson E, Olofsson J, Skoglund L, Yousef J, Pin E, Christ W, Olausson M, Hedhammar M, Tegel H, Mangsbo S, Phillipson M, Månberg A, Hober S, Nilsson P, Thålin C. SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.. [DOI: 10.1101/2021.01.03.21249162] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
168 Weinberger T, Steffen J, Osterman A, Mueller TT, Muenchhoff M, Wratil PR, Graf A, Krebs S, Quartucci C, Spaeth PM, Grabein B, Adorjan K, Blum H, Keppler OT, Klein M. Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany. Clin Infect Dis 2021:ciaa1935. [PMID: 33388756 DOI: 10.1093/cid/ciaa1935] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 22.0] [Reference Citation Analysis]
169 Amin AB, Kellogg JT, Adams C, Dube WC, Collins MH, Lopman BA, Johnson TM, Weitz J, Fridkin SK. Risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seropositivity among nursing home staff. ASHE 2021;1:e35. [DOI: 10.1017/ash.2021.193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Post N, Eddy D, Huntley C, van Schalkwyk MCI, Shrotri M, Leeman D, Rigby S, Williams SV, Bermingham WH, Kellam P, Maher J, Shields AM, Amirthalingam G, Peacock SJ, Ismail SA. Antibody response to SARS-CoV-2 infection in humans: A systematic review. PLoS One 2020;15:e0244126. [PMID: 33382764 DOI: 10.1371/journal.pone.0244126] [Cited by in Crossref: 186] [Cited by in F6Publishing: 200] [Article Influence: 93.0] [Reference Citation Analysis]
171 Schwartz KL, Achonu C, Buchan SA, Brown KA, Lee B, Whelan M, Wu JH, Garber G. Epidemiology, clinical characteristics, household transmission, and lethality of severe acute respiratory syndrome coronavirus-2 infection among healthcare workers in Ontario, Canada. PLoS One 2020;15:e0244477. [PMID: 33370384 DOI: 10.1371/journal.pone.0244477] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
172 Dopico XC, Muschiol S, Christian M, Hanke L, Sheward DJ, Grinberg NF, Rorbach J, Bogdanovic G, Mcinerney GM, Allander T, Wallace C, Murrell B, Albert J, Hedestam GBK. Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden.. [DOI: 10.1101/2020.12.24.20248821] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
173 Abohamr SI, Aldossari MA, Alaklobi FA, Amer HA, Alzarzour SH, Abdelhamid SW, Aljunaidi O, Badhawi OS, Siddiqui S, Jumaa H, Badwi M, Elsheikh E. Clinical characteristics and in-hospital outcome of medical staff infected with COVID-19 in Saudi Arabia. A retrospective single-center study. Saudi Med J. 2020;41:1336-1343. [PMID: 33294892 DOI: 10.15537/smj.2020.12.25514] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
174 Hassan SS, Seigerud Å, Mühr LSA, Kleppe SN, Pin E, Månberg A, Hober S, Nilsson P, Engstrand L, Elfström KM, Blomqvist J, Lundgren KC, Dillner J. SARS-CoV-2 infections among personnel providing home care services for the elderly in Stockholm, Sweden.. [DOI: 10.1101/2020.12.18.20248511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
175 Galán MI, Velasco M, Casas ML, Goyanes MJ, Rodríguez-Caravaca G, Losa-García JE, Noguera C, Castilla V; Working Group Alcorcón COVID-19 investigators., Working Group Alcorcón COVID-19 investigators. Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital. Enferm Infecc Microbiol Clin (Engl Ed) 2020:S0213-005X(20)30418-3. [PMID: 33485676 DOI: 10.1016/j.eimc.2020.11.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
176 Dillner J, Elfström KM, Blomqvist J, Engstrand L, Uhlén M, Eklund C, Boulund F, Lagheden C, Hamsten M, Nordqvist-kleppe S, Seifert M, Hellström C, Olofsson J, Andersson E, Falk AJ, Bergström S, Hultin E, Pin E, Pimenoff VN, Hassan S, Månberg A, Nilsson P, Hedhammar M, Hober S, Mattsson J, Mühr LSA, Lundgren KC. Screening for high amounts of SARS-CoV-2 identifies pre-symptomatic subjects among healthy healthcare workers.. [DOI: 10.1101/2020.12.13.20248122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Kantele A, Lääveri T, Kareinen L, Pakkanen SH, Blomgren K, Mero S, Patjas A, Virtanen J, Uusitalo R, Lappalainen M, Järvinen A, Kurkela S, Jääskeläinen AJ, Vapalahti O, Sironen T. SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors. Travel Med Infect Dis 2021;39:101949. [PMID: 33321195 DOI: 10.1016/j.tmaid.2020.101949] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
178 Brehm TT, Schwinge D, Lampalzer S, Schlicker V, Küchen J, Thompson M, Ullrich F, Huber S, Schmiedel S, Addo MM, Lütgehetmann M, Knobloch JK, Schulze Zur Wiesch J, Lohse AW. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study. Int J Hyg Environ Health 2021;232:113671. [PMID: 33338782 DOI: 10.1016/j.ijheh.2020.113671] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
179 Díez-manglano J, Marquínez MNS, García AÁ, Alcalá-rivera N, Riesco IM, Aseguinolaza MG, Pérez JLB, Bailon MM, Ruiz AEL, Gómez MG, Cilleros CM, Fontan PMP, Vázquez LA, Encinar JCB, Boixeda R, Sánchez RG, de la Peña Fernández A, Amigo JL, Sevilla JE, Garcia MG, Escalante MDM, Gamboa JOM, Gonzalez ALM, Bermejo CL, Santos JMA, for the SEMI-COVID-19 Network. Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry.. [DOI: 10.1101/2020.11.23.20236810] [Reference Citation Analysis]
180 Rashid-Abdi M, Krifors A, Sälléber A, Eriksson J, Månsson E. Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study. Infect Dis (Lond) 2021;53:169-75. [PMID: 33232190 DOI: 10.1080/23744235.2020.1849787] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
181 Ganz-Lord FA, Segal KR, Rinke ML. COVID-19 symptoms, duration, and prevalence among healthcare workers in the New York metropolitan area. Infect Control Hosp Epidemiol 2021;42:917-23. [PMID: 33213542 DOI: 10.1017/ice.2020.1334] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
182 Kharlamova N, Dunn N, Bedri SK, Jerling S, Almgren M, Faustini F, Gunnarsson I, Rönnelid J, Pullerits R, Gjertsson I, Lundberg K, Månberg A, Pin E, Nilsson P, Hober S, Fink K, Fogdell-hahn A. SARS-CoV-2 serological tests can generate false positive results for samples from patients with chronic inflammatory diseases.. [DOI: 10.1101/2020.11.13.20231076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
183 Kahlert CR, Persi R, Güsewell S, Egger T, Leal-neto OB, Sumer J, Flury D, Brucher A, Lemmenmeier E, Möller JC, Rieder P, Stocker R, Vuichard-gysin D, Wiggli B, Albrich WC, Flury BB, Besold U, Fehr J, Kuster SP, Mcgeer A, Risch L, Schlegel M, Friedl A, Vernazza P, Kohler P. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among Hospital Workers – a multicentre cross-sectional study.. [DOI: 10.1101/2020.11.10.20229005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Kucharski AJ, Nilles EJ. Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings. Lancet Infect Dis 2020;20:1351-2. [PMID: 32758436 DOI: 10.1016/S1473-3099(20)30579-X] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]